TenX Keane Acquisition closes IPO, raises $66M in gross proceeds

CITIUS ONCOLOGY, INC.

IPO of 6,600,000 units at $10.00/unit closed on Oct 18, 2022; gross proceeds $66,000,000.
Simultaneous private placement of 394,000 units to sponsor at $10.00/unit generated $3,940,000 additional.
Total of $67,320,000 placed in trust account ($10.20 per unit) for benefit of public shareholders.
Audited balance sheet shows $453,111 shareholders' deficit; going concern note highlights risk if business combination not completed within 9-month period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.